FDA Approves First Alzheimer's Drug Since 2003
Have you heard the news? The Food & Drug Administration (FDA) has approved a new drug called Aduhelm (or aducanumab) to combat the onset of Alzheimer’s disease. This is the first drug to receive an approval of any form for Alzheimer’s since 2003.
Alzheimer’s is one of the most debilitating and deadly diseases facing Americans. It was the sixth leading cause of death in the U.S. prior to the pandemic. The availability of a new drug to fight it is exciting news, but there is some controversy surrounding the drug and its approval. So, let’s take a closer look at Aduhelm, its FDA approval, and why it’s controversial.
Facts, figures, and quotes can be found in the FDA’s press release, prescribing information, or on Aduhelm’s approval, unless cited elsewhere.
What Does Aduhelm Claim to Do?
The results of trials for Aduhelm have been extremely promising, making it the first treatment that’s shown signs of actually slowing the disease’s progression. These signs are positive because of the novel approach this treatment takes toward combatting Alzheimer’s disease. Should Aduhelm prove to be effective at slowing down the progression of Alzheimer’s, it could answer questions for a disease we still don’t know a ton about and pave the way for other treatment options. So, how does it work?
Aduhelm is given through an intravenous (IV) infusion and targets beta-amyloid plaque in the brain, which is a sign of Alzheimer’s disease. It’s believed that beta-amyloid plaque can be toxic to the brain and, as it collects between neurons, disrupts cell function in the brain. Though more research is needed on this to determine the exact ties between Alzheimer’s and the plaques, these studies are done to better understand the relationship, not confirm it.
It’s a promising new option for the millions of Americans diagnosed with Alzheimer’s and their families.
Getting back to Aduhelm, the drug is a protein that acts as an antibody to the beta-amyloid plaques, reducing the number of them in the brain, and potentially, slowing the onset of Alzheimer’s disease. It’s important to remember that Aduhelm only purports to slow the progression of the disease. It isn’t a cure, and it can’t reverse any damage that has already been done. Despite that, it’s a promising new option for the millions of Americans diagnosed with Alzheimer’s and their families.
Is the Approval of Aduhelm a Done Deal?
The FDA has reserved the right to rescind Aduhelm’s conditional approval in the future, and it’s also requiring another large Phase IV trial to fully determine the benefits of the drug. The results of this new trial could either confirm the approval of this exciting new drug or take its developers back to square one.
Would Medicare Cover It?
Considering 72 percent of Alzheimer’s patients are 75 and older, thus squarely in Medicare-age, the question of whether Medicare will cover the new drug or not is an important one, especially considering its cost. The annual cost of Aduhelm is around $56,000 per patient. Keep in mind, that is the list price, which is the cost if you didn’t have insurance. It’s not known for sure if Medicare will cover the drug entirely or even at all. Medicare could enact a coverage determination to cover only part of the treatment or not cover it at all if the program decides that the clinical data doesn’t support coverage.
It’s yet not known for sure if Medicare will cover the drug entirely or even at all.
If Aduhelm is covered by Medicare, it could be covered under Medicare Part B, since it is likely to be administered in an outpatient setting by IV infusion. This would leave you with two out-of-pocket costs. Coverage would start once you hit your Part B deductible, which is $203 in 2021, and would include a 20-percent coinsurance. Medicare Part C plans can also attempt to negotiate with the drug’s manufacturer, Biogen, for lower prices and offer additional coverage, though this will vary from plan to plan. Luckily, Medicare does cover other facets of dementia care also, so you’ll receive assistance for the many aspects of treatment and care.
What’s the Controversy?
Of course, Aduhelm’s FDA approval has not been without controversy, which is why the FDA has only given a conditional approval. There are actually three controversial subjects that have been touched on with Aduhelm that must be addressed.
You probably guessed the first — the price. Biogen has been under fire recently for the $56,000 price tag placed on the drug, though Biogen’s CEO, Michel Vounatsos, maintains the pricing is fair. This is despite the drug being priced $31,000 to $46,000 more than what earlier expectations predicted. With the majority of the likely users of Aduhelm being on Medicare, this cost will likely fall on the Medicare program itself, causing concerns for both the long-term viability of the popular program and for the taxpayers that fund it. That’s a lot of risk for a drug that has had mixed results for effectiveness in studies, which brings us to the next controversial subject.
A number of independent groups and doctors cast serious doubt on the effectiveness of Aduhelm in slowing the onset of Alzheimer’s.
It may be surprising, since the FDA approved the drug, but there are a lot of questions about just how effective Aduhelm is, explaining why the FDA is ordering another large trial. In fact, a number of independent groups and doctors cast serious doubt on the effectiveness of Aduhelm in slowing the onset of Alzheimer’s. Even the FDA’s own advisory panel declined to endorse the treatment. Biogen itself lost faith in Aduhelm at one point, ceasing both of its ongoing trials in 2019 when their data revealed the drug likely wasn’t beneficial. They ultimately restarted trials after further data in one of the trials showed success.
And lastly, there are reports of some serious side effects like brain swelling and microhemorrhage in the brain, and the theory of beta-amyloid plaque causing Alzheimer’s has not been yet proven. When you consider all of these points, you can understand why there are worries about the approval of the drug, even if it’s conditional upon another large trial.
● ● ●
Ultimately, a lot hinges on the final trial that has been ordered by the FDA. As part of the approval press release, the FDA stated that lack of treatments and drugs fulfilling the need of those with Alzheimer’s was the main reason for this approval. This has drawn criticism from some in the medical field who have noted that, while unmet need is an important contextual factor for approval, it is by no means the most important and shouldn’t be the defining reason. Alternatively, patient advocate groups like the Alzheimer’s Association believe that new treatments can reinvigorate a field, leading to even better treatments down the road.
So, while there are certainly valid and major concerns facing Aduhelm, a positive Phase IV trial could alleviate some, though not all, of the associated worries. Regardless, at the very least, this approval could signal a promising new direction for Alzheimer’s research, even if Aduhelm is only a stepping stone in the journey toward treating Alzheimer’s disease.
Featured Blogs
- Learning to Ski
- The Stories Behind Classic Christmas Carols
- 4 More Tips to Make Christmas Tree Hunt Less Stressful
- Why Do We Celebrate That? Other Festive Holidays
- A Senior Guide to Boston
- A Senior Guide to Edinburgh
- How Does Medicare Cover Osteoporosis?
- What are Ulcers?
- Medicare's Coverage of Parkinson's Disease
- What is a Cognitive Screening?
- Spooky Spots for Halloween 2023
- 4 Ways to Keep Trick-or-Treating Safe
- 10 Classic Horror Books for Halloween
- Here's What Medicare Costs in 2024
- 10 Safety Rules for Seniors Who Enjoy Hunting
- Medicareful Living is Changing Its Name — Here's Why
- CMS Releases 2024 Medicare Advantage and Part D Costs
- Can You Keep Your Medicare Plan Each Year?
- A Senior Guide to Lucerne
- Is Expensive Cookware Worth It?
- The Drug Prices Medicare Can Directly Negotiate
- Does Medicare Ever Cover Cosmetic Surgery?
- A Senior Guide to Barcelona
- How Does COBRA Work with Medicare?
- Different Ways Medicare Can Cover Drug Costs
- Medicareful Living is Changing Its Name — Here's Why
- CMS Releases 2024 Medicare Advantage and Part D Costs
- Can You Keep Your Medicare Plan Each Year?
- Medicareful Travel: Senior Trip to Lucerne
- Is Expensive Cookware Worth It?
- The Drug Prices Medicare Can Directly Negotiate
- Does Medicare Ever Cover Cosmetic Surgery?
- Medicareful Travel: Senior Trip to Barcelona
- How Does COBRA Work with Medicare?
- Different Ways Medicare Can Cover Drug Costs
- All About Enrolling in Social Security
- Medicareful Travel: Senior Trip to the Madrid
- Does Medicare Cover Open-Heart Surgery?
- Exercise Tips for Summer
- Medicareful Travel: Senior Trip to Lisbon
- Hosting a Safe Summer Barbecue
- Senior Summer Barbecue Tips
- Does Medicare Cover Biopsies?
- 5 Foods to Avoid if You Have High Blood Pressure
- Medicareful Travel: Senior Trip to the Finger Lakes
- Does Medicare Cover Endoscopies?
- Ways Seniors Can Recover from a Workout
- Is Chocolate Healthy for You?
- Understanding Adult ADHD
- How Does Medicare Cover Hypertension?
- The Symptoms and Treatment of Parkinson's Disease
- How to Determine What Temperature to Use When Cooking
- Eating Healthy on a Budget
- Keeping Fit on Vacation
- Is Your Tonsillectomy Covered by Medicare?
- Tips for the Perfect Hard-Boiled Eggs
- Kitchen First Aid Tips
- What Does FDA-Approved Mean?
- Medicareful Travel: Senior Guide to New York City
- How to Caramelize Onions
- Why Do We Celebrate That? April Fools’ Day
- Medicare and Powers of Attorney
- The Essential Role of Eggs in Cooking
- What are Different Types of Complementary
and Alternative Medicine? - Tips for Remembering to Take Your Medicine
- What is Medicare Part E?
- Building Your Basic At-Home Senior Gym
- How to Make Stovetop Popcorn
- Medicareful Travel: Senior Trip to New Orleans
- How to Navigate & Read Academic Articles
- Phytonutrients: What Plant Color Says About Nutrition
- How to Prevent or Reduce Inflammation
- Osteoporosis: Risk Factors, Signs, and Treatment
- How to Make Homemade Pretzels
- Researching Your Ancestry and Family Tree
- How Medicare and Social Security Work Together
- What is Nordic Walking?
- Food Questions You've Been Embarrassed to Ask
- How Medicare Changed for 2023 and Beyond
- Tips for Using a Microwave
- How to Clean Your Ears Safely
- Skiing as a Healthy Hobby for Seniors
- 3 More Great Places to Celebrate New Year's Eve
- Why Do We Celebrate That? More New Year's Eve Traditions
- Panettone, the Italian Christmas Dessert
- A Simple Homemade Gingerbread Recipe
- How to Make Christmas Decorating Jollier
- The Science of Winter Weight Gain
- Seasonal Picks: 3 Foods You Should Try This Winter
- 5 Tips to Make Getting Your Christmas Tree Stress-Free
- Show-Stopping Potato Side Dishes for Thanksgiving
- Dishes to Impress Your Friends: Boeuf Bourguignon
- Holiday Travel Tips to Reduce Stress
- Does Medicare Cover Pain Management?
- Is Hunting a Healthy Senior Hobby?
- Ways You Can Get More Politically Involved
- What are Medicare's Lifetime Reserve Days?
- Spooky Spots for Seniors Halloween 2022
- How to Make Soul Cakes for Halloween
- Jack O' Lantern Carving Tips for Halloween
- Easy Ways to Peel a Potato
- 2023 Social Security COLA Largest in Decades
- Exercise Tips for Autumn
- How to Make Candy Apples at Home
- Why are Medicare Insurance Sales Calls Recorded?
- Here's What Medicare Costs in 2023
- CMS Updates Medicare Enrollment Rules for 2023
- Medicareful Travel: Senior Trip to London
- Does Medicare Cover Insomnia Treatment?
- Healthy and Easy Homemade Dog Treats
- The FDA Finalizes Ruling to Increase Access to Hearing Aids
- What the Inflation Reduction Act of 2022 Means for Medicare
- Tips to Make Flying and Airports Less Stressful
- CMS Projects Lower 2023 Part D Average Costs
- The 15 Golden Rules of Airplane Etiquette
- How Often Should You Shower?
- What are Medicare Pilot Programs?
- How to Care for Your Cast Iron Cookware
- Confronting a Loved One About Hurtful Behavior
- What Does Creditable Coverage Mean for Medicare?